Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-01-01

Clinical Trial Update: Utility of Presepsin in Children Sepsis

View source ↗

Summary

A clinical trial update investigates the utility of presepsin as a biomarker for pediatric sepsis (NCT02643121); the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Presepsin (presepsin)

Snippet

Sponsor: Brno University Hospital | Conditions: Sepsis Syndrome | Status: UNKNOWN